质子泵抑制剂的使用状况不会改变肝硬化的微生物组特征。
Proton pump inhibitor use status does not modify the microbiome signature for cirrhosis.
机构信息
Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
NAFLD Research Center, Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
出版信息
Cell Metab. 2021 Mar 2;33(3):457. doi: 10.1016/j.cmet.2021.02.013.
PMID:33657386
Abstract
Oh et al. address concerns about the influence of proton pump inhibitor (PPI) use on a gut microbiome signature for cirrhosis. By removing PPI using subjects from the training cohort and retraining a 19-species Random Forest model, they demonstrate the impact of PPI usage on the signature's diagnostic accuracy is minimal.
摘要
哦等人解决了质子泵抑制剂 (PPI) 使用对肝硬化肠道微生物组特征影响的问题。他们从训练队列中去除 PPI 使用的受试者，并重新训练一个 19 种物种的随机森林模型，证明了 PPI 使用对特征诊断准确性的影响很小。
Zotero 插件